EQUITY ALERT: Rosen Law Firm Announces Filing of Securities

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against SuperCom Ltd. – SPCB

NEW YORK, Jan. 08, 2016 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of SuperCom Ltd. (NASDAQ: SPCB ) common stock from June 1, 2015 through November 27, 2015, all dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for SuperCom investors under the federal securities laws.

To join the SuperCom class action, go to the firm’s website at http://rosenlegal.com/cases-799.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll free at 866-767-3653 or email pkim@rosenlegal.com or kchan@rosenlegal.com for more information on the class action.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.

According to the lawsuit, throughout the Class Period, defendants issued false and misleading statements to investors and/or failed to disclose that: (1) SuperCom was having difficulty closing certain governmental sales and the revenue associated with those sales would be substantially delayed, (2) SuperCom’s “pipeline” was neither strong nor “broadening,”; (3) as a result, SuperCom was not on track to achieve the financial results defendants had led the market to expect during the Class Period, and (4) as a result, defendants’ statements about SuperCom’s business, operations, and prospects, were false and misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 8, 2016. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to the firm’s website at http://rosenlegal.com/cases-799.html for more information. You may also contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at 866-767-3653 or via email at pkim@rosenlegal.com or kchan@rosenlegal.com .

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.

 

Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. Kevin Chan, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 34th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 lrosen@rosenlegal.com pkim@rosenlegal.com kchan@rosenlegal.com www.rosenlegal.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Waystar Sees Stellar Q1 2025 Results With Revenue Increase

Updated Category News Views 624

Waystar Reports Stellar Q1 2025 Financial Results In the latest announcement, Waystar Holding Corp. (NASDAQ: WAY) has highlighted significant achievements for the first quarter of 2025, showcasing robust financial progress and promising future guidance. The company achieved an impressive revenue growth rate of 14% year-over-year, reflecting its continuing success as a...

Continue Reading
Innovative Power MOSFET to Boost Efficiency in AI Server Tech

Updated Category News Views 180

Revolutionizing AI Server Power Solutions ROHM Semiconductor has taken a significant step in advancing the technology landscape with their latest power MOSFET, the RS7P200BM. This innovative component is crafted specifically for AI servers, functioning within a compact 5.0mm × 6.0mm package. The introduction of this 100V power MOSFET stems from the increasing demands for...

Continue Reading
Sarclisa Gains EU Approval for New Multiple Myeloma Treatment

Updated Category News Views 319

Sarclisa Approved in the EU for New Treatment of Multiple Myeloma Sarclisa has recently achieved a significant milestone by obtaining approval in the European Union as the first anti-CD38 therapy designed for use in combination with the standard-of-care regimen known as VRd, to treat adult patients with newly diagnosed multiple myeloma (NDMM) who are not eligible for...

Continue Reading
Lifecore Biomedical Investors: Navigate Legal Rights with Precision

Updated Category News Views 83

Your Rights as a Lifecore Investor If you’ve invested in Lifecore Biomedical, Inc., you're at a key juncture as you navigate the complexities of legal action stemming from potential corporate misconduct. Understanding your options is crucial during this time. Details on the Class Action The Portnoy Law Firm has officially announced a class action for Lifecore...

Continue Reading
Natural Grocers Crowned Top Organic Retailer in 2024 Contest

Updated Category News Views 237

Natural Grocers Leads the Way in Organic Retail Natural Grocers is proud to announce that it has been named "Best Natural Food Stores for 2024" in a contest hosted by Green Matters. This award is a significant achievement, highlighting the company’s dedication to offering premium natural and organic products. A Well-Deserved Honor This recognition resulted from a public...

Continue Reading